Research Progress on Echocardiographic First-Phase Ejection Fraction in Assessing Early Left Ventricular Systolic Dysfunction

YE Qing; SU Zhongzhen

doi:10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20240425.003

您当前的位置：

首页 >

文章列表页 >

Research Progress on Echocardiographic First-Phase Ejection Fraction in Assessing Early Left Ventricular Systolic Dysfunction

Review | 更新时间：2024-06-05

- Research Progress on Echocardiographic First-Phase Ejection Fraction in Assessing Early Left Ventricular Systolic Dysfunction
- Journal of Sun Yat-sen University(Medical Sciences) Vol. 45, Issue 3, Pages: 377-382(2024)
- 作者机构：
  
  中山大学附属第五医院超声科，广东珠海 519000
- 作者简介：
  
  SU Zhongzhen； E-mail： sp9313@126.com
- 基金信息：
- DOI：10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20240425.003
  CLC： R540.45
- Published：20 May 2024，
  
  Received：11 March 2024，
  
  Accepted：24 April 2024
扫描看全文
叶青,苏中振.超声心动图第一期相射血分数早期评估左室收缩功能障碍的研究进展[J].中山大学学报（医学科学版）,2024,45(03):377-382.

YE Qing,SU Zhongzhen.Research Progress on Echocardiographic First-Phase Ejection Fraction in Assessing Early Left Ventricular Systolic Dysfunction[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(03):377-382.
叶青,苏中振.超声心动图第一期相射血分数早期评估左室收缩功能障碍的研究进展[J].中山大学学报（医学科学版）,2024,45(03):377-382. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20240425.003.

YE Qing,SU Zhongzhen.Research Progress on Echocardiographic First-Phase Ejection Fraction in Assessing Early Left Ventricular Systolic Dysfunction[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(03):377-382. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20240425.003.

摘要

第一期相射血分数（EF1）是指从左室舒张末期至主动脉血流速度达到峰值的左室容积变化百分比，本文综述了EF1在早期检测主动脉瓣狭窄、稳定性冠状动脉疾病、新型冠状病毒肺炎等患者左室收缩功能障碍的研究进展，分析其在临床应用中的优势与局限性，并对其未来发展提出展望，即EF1作为一个反映早期左室收缩功能障碍的新指标，具备临床推广应用的可能。

Abstract

First-phase ejection fraction （EF1） is the volume change rate of left ventricle （LV） from end-diastole to the time of peak aortic velocity. This article reviewed the research progress of EF1 in detecting early left ventricular systolic dysfunction （LVSD） of patients with aortic stenosis （AS）， stable coronary artery disease （SCAD）， Coronavirus Disease 2019 （COVID-19） and so on， analyzed the advantages and limitations of EF1 in clinical application， and envisioned the future development of EF1 as a novel predictor of early LVSD in clinical use.

关键词

第一期相射血分数射血分数超声心动图左室收缩功能障碍斑点追踪技术

Keywords

first-phase ejection fraction （EF1）ejection fractionechocardiographyleft ventricular systolic dysfunction （LVSD）speckle tracking technique

references

中华医学会心血管病学分会影像学组，中国医师协会放射医师分会心血管专业，委员会. 无创性心血管影像学技术临床适用标准中国专家共识［J］. 中华心血管病杂志，2020， 48（11）： 906-921.

Chinese Society of Cardiology， Division of Cardiovascular Imaging； Chinese Association of Radiologists， Division of Cardiovascular Imaging. Chinese expert consensus on the clinical appropriate use criteria of non-invasive cardiovascular imaging modalities ［J］. Chin J Cardiol，2020， 48（11）： 906-921.

Halliday BP， Senior R， Pennell DJ. Assessing left ventricular systolic function： from ejection fraction to strain analysis ［J］. Eur Heart J， 2021， 42（7）：789-797.

中国医师协会超声医师分会心脏超声专业委员会. 二维斑点追踪超声心动图心肌纵向应变规范化检查中国专家共识（2023版）［J］. 中华超声影像学杂志， 2023， 32（4）： 277-287.

Echocardiography Committee of Chinese Ultrasound Doctor Association. Chinese expert consensus on standardized myocardial longitudinal strain imaging using two-dimensional speckle-tracking echocardiography （version 2023）［J］. Chin J Ultrasonogr， 2023， 32（4）： 277-287.

Marzlin N， Hays AG， Peters M， et al. Myocardial work in echocardiography ［J］. Circ Cardiovasc Imaging， 2023， 16（2）：e014419.

Gu H， Li Y， Fok H， et al. Reduced first-phase ejection fraction and sustained myocardial wall stress in hypertensive patients with diastolic dysfunction： a manifestation of impaired shortening deactivation that links systolic to diastolic dysfunction and preserves systolic ejection fraction ［J］. Hypertension， 2017， 69（4）：633-640.

Bing R， Gu H， Chin C， et al. Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis ［J］. Heart， 2020， 106（16）：1236-1243.

Gu H， Azukaitis K， Doyon A， et al. Decline in left ventricular early systolic function with worsening kidney function in children with chronic kidney disease： Insights from the 4C and HOT-KID studies ［J］. J Am Soc Echocardiogr， 2024， 37（3）：356-363.

Gu H， Bing R， Chin C， et al. First-phase ejection fraction by cardiovascular magnetic resonance predicts outcomes in aortic stenosis ［J］. J Cardiovasc Magn Reson， 2021， 23（1）：73.

Sun Z， Cai Y， Yang Y， et al. Early left ventricular systolic function is a more sensitive predictor of adverse events after heart transplant ［J］. Int J Cardiol， 2024， 398：131620.

Fleury MA， Clavel MA. Sex and race differences in the pathophysiology， diagnosis， treatment， and outcomes of valvular heart diseases ［J］. Can J Cardiol， 2021， 37（7）：980-991.

Otto CM， Nishimura RA， Bonow RO， et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease： a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines ［J］. Circulation， 2021， 143（5）：e72-e227.

Vahanian A， Beyersdorf F， Praz F， et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease ［J］. Eur Heart J， 2022， 43（7）：561-632.

Bing R， Cavalcante JL， Everett RJ， et al. Imaging and impact of myocardial fibrosis in aortic stenosis ［J］. JACC Cardiovasc Imaging， 2019， 12（2）：283-296.

Gu H， Saeed S， Boguslavskyi A， et al. First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction ［J］. JACC Cardiovasc Imaging， 2019， 12（1）：52-63.

Tsao CW， Aday AW， Almarzooq ZI， et al. Heart disease and stroke statistics-2023 update： a report from the American heart association ［J］. Circulation， 2023， 147（8）：e93-e621.

Massera D， Hu M， Delaney JA， et al. Adverse cardiac mechanics and incident coronary heart disease in the cardiovascular health study ［J］. Heart， 2022， 108（7）：529-535.

Takeuchi M， Wu VC. Application of left ventricular strain to patients with coronary artery disease ［J］. Curr Opin Cardiol， 2018， 33（5）：464-469.

Minczykowski A， Zwanzig M， Dziarmaga M， et al. First-phase left ventricular ejection fraction as an early sign of left ventricular dysfunction in patients with stable coronary artery disease ［J］. J Clin Med， 2023， 12（3）：868.

Zhang JJ， Dong X， Liu GH， et al. Risk and protective factors for COVID-19 morbidity， severity， and mortality ［J］. Clin Rev Allergy Immunol， 2023， 64（1）：90-107.

Gu H， Cirillo C， Nabeebaccus AA， et al. First-phase ejection fraction， a measure of preclinical heart failure， is strongly associated with increased mortality in patients with COVID-19 ［J］. Hypertension， 2021， 77（6）：2014-2022.

August P. Chronic kidney disease - another step forward ［J］. N Engl J Med， 2023， 388（2）：179-180.

Villasis-Keever MA， Zurita-Cruz JN， Zepeda-Martinez C， et al. Adipokines as predictive factor of cardiac function in pediatric patients with chronic kidney disease ［J］. Front Endocrinol （Lausanne）， 2023， 14：1120445.

Ter Maaten JM， Damman K， Verhaar MC， et al. Connecting heart failure with preserved ejection fraction and renal dysfunction： the role of endothelial dysfunction and inflammation ［J］. Eur J Heart Fail， 2016， 18（6）：588-598.

Bragazzi NL， Zhong W， Shu J， et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017 ［J］. Eur J Prev Cardiol， 2021， 28（15）：1682-1690.

Jin C， Chen G， Chen S， et al. First-phase ejection fraction to predict adverse outcomes in patients with heart failure ［J］. Int J Cardiol， 2024， 399：131612.

Glikson M， Nielsen JC， Kronborg MB， et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy ［J］. Europace， 2022， 24（1）：71-164.

Daubert C， Behar N， Martins RP， et al. Avoiding non-responders to cardiac resynchronization therapy： a practical guide ［J］. Eur Heart J， 2017， 38（19）：1463-1472.

Gu H， Sidhu BS， Fang L， et al. First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes ［J］. JACC Cardiovasc Imaging， 2021， 14（12）：2275-2285.

Stehlik J， Kobashigawa J， Hunt SA， et al. Honoring 50 years of clinical heart transplantation in circulation： In-depth state-of-the-art review ［J］. Circulation， 2018， 137（1）：71-87.

陈良万，李虔桢，戴小福，等. 心脏移植的发展现状和新挑战［J］. 器官移植， 2023， 14（1）： 31-41.

Chen LW， Li QZ， Dai XF， et al. Development status and new challenges of heart transplantation［J］. Organ Transpl， 2023， 14（1）： 31-41.

Yoshizato T， Edwards WD， Alboliras ET， et al. Safety and utility of endomyocardial biopsy in infants， children and adolescents： a review of 66 procedures in 53 patients ［J］. J Am Coll Cardiol， 1990， 15（2）：436-442.

Badano LP， Miglioranza MH， Edvardsen T， et al. European association of cardiovascular imaging/cardiovascular imaging department of the Brazilian society of cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation ［J］. Eur Heart J Cardiovasc Imaging， 2015， 16（9）：919-948.

Gu H， Singh C， Li Y， et al. Early ventricular contraction in children with primary hypertension relates to left ventricular mass ［J］. J Hypertens， 2021， 39（4）：711-717.

Magne J， Aboyans V. First-phase left ventricular ejection fraction： a small step for myocardial assessment， a big leap for aortic stenosis ［J］. Eur Heart J Cardiovasc Imaging， 2021， 22（6）：658-659.

Muraru D， Cecchetto A， Cucchini U， et al. Intervendor consistency and accuracy of left ventricular volume measurements using three-dimensional echocardiography ［J］. J Am Soc Echocardiogr， 2018， 31（2）：158-168.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Left Ventricle Longitudinal Strain Parameters Are Effective for Differentiating Cardiac Amyloidosis from Primary Hypertensive Left Ventricular Hypertrophy

Related Author

FENG Ri-qing

MENG Yuan-li

LIU Ying-mei

QIU Qiong

ZHENG Shao-xin

DENG Bing-qing

WEI Yu-lin

Related Institution

Department of Cardiology， Sun Yat-sen Memorial Hospital， Sun Yat-sen University

Postal code：510080
Tel：020-87331643，87330827 Email：xbmed@mail.sysu.edu.cn
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰